VSV. D. Skrypko

V. D. Skrypko

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


V. D. Skrypko has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Concept of venous thromboembolism prophylaxis following endovenous thermal procedures for chronic venous disease of the lower limbs

    by O. Yu. Atamaniuk, V. D. Skrypko, S. V. Fedorov, V. M. Atamaniuk

    Aim. To enhance the safety and efficacy of thermal ablation procedures in patients with chronic venous disease (CVD) of the lower limbs by developing a strategy for venous thromboembolism (VTE) prevention. Materials and methods. This single-center, prospective, open-label study included 420 consecutive patients with CVD (C2–C6). Participants underwent radiofrequency ablation (RFA, n = 206) or endovenous laser ablation (EVLA, n = 214). At the first stage, VTE risk stratification was conducted using the Caprini scale; at the second stage, the optimal thromboprophylaxis algorithm was selected. Patients were divided into two homogeneous groups. Group 1 (208 patients) received VTE prevention with standard elastic compression only, while Group 2 (212 patients) received prophylaxis based on the proposed algorithm. The incidence of postoperative VTE and bleeding complications was assessed. Results. According to VTE risk stratification, 23.6 % of patients were classified as low risk, 63.1 % as moderate risk, 9.0 % as high risk, 3.1 % as very high risk, and 1.2 % as the highest risk. Based on the second phase analysis, 12 patients (2.9 %) of Group 1 developed thrombotic complications during the early postoperative period: EHIT class II was diagnosed in 3 cases (0.7 %) after EVLA and in 2 cases (0.5 %) after RFA. Additionally, distal deep vein thrombosis (DVT) was detected in 7 patients (1.7 %) with high VTE risk on postoperative day 7: 3 after EVLA and 4 after RFA. Implementation of the proposed thromboprophylaxis strategy significantly reduced the total incidence of thrombotic complications compared to Group 1 (0.4 % vs. 2.9 %; p = 0.031). In Group 2, only one patient (0.4 %) with moderate VTE risk was diagnosed with distal DVT. Among 39 patients (18.3 %) who received prophylactic acetylsalicylic acid or rivaroxaban, a statistically significant increase in ecchymosis occurrence was observed (p = 0.018). Conclusions. Implementing a differentiated, risk-oriented thromboprophylaxis strategy significantly (p = 0.031) reduced the incidence of VTE from 2.9 % to 0.4 %, p = 0.031, without increasing the risk of clinically significant bleeding.

  • Open Access

    Identification of microRNA signatures in thyroid cancer

    by A. Ya. Pasko, V. D. Skrypko

    Aim: to identify differentially expressed microRNAs (miRNAs) in papillary and follicular thyroid cancer (TC) and to evaluate their potential as diagnostic and prognostic biomarkers. Materials and methods. Three GEO datasets were analyzed: GSE104006 (20 samples of papillary TC and 6 normal tissues), GSE191117 (50 samples of papillary TC and 50 normal samples), and GSE62054 (17 samples of follicular carcinoma and 8 benign tumors). Differentially expressed miRNAs were identified with |log2FC| >1 and p < 0.05 with subsequent FDR correction DIANA miRPath v. 3 was used to assess signaling pathways, miRNet v. 2.0 to identify target genes, and ShinyGO v. 0.82 for functional annotation. Prognostic significance was evaluated using ENCORI database. Results. Six miRNAs were selected: hsa-miR-15a-5p, hsa-miR-146b-5p, hsa-miR-199b-5p, hsa-miR-221-5p, hsa-miR-222-3p, and hsa-miR-484. They potentially regulate over 2,000 target genes, including RET, CCND1, TP53, HIF1A, IL6, and IL1B, which are associated with the development and progression of malignant tumors. GEO analysis revealed their involvement in the regulation of metabolism, biosynthesis, protein modification, as well as in the binding functions of transcription factors, DNA, and RNA. Nineteen KEGG signaling pathways were identified, 13 of which are closely associated with carcinogenesis. Prognostic analysis indicated that low expression of hsa-miR-146b-5p and hsa-miR-221-5p correlate with significantly poorer overall survival in TC patients. Conclusions. The proposed panel of six miRNAs may have significant potential for the differential diagnosis of papillary and follicular thyroid cancer, risk stratification, and prognosis; hsa-miR-146b-5p and hsa-miR-221-5p demonstrated the greatest prognostic value. Further experimental studies are needed for the clinical validation of these biomarkers.

  • Open Access

    Comprehensive assessment of intestinal anastomosis viability in rectal cancer: fluorescence angiography, inflammatory biomarkers, and morphological verification

    by Vasyl Skrypko, Vasyl Vasyliv

    Introduction. Anastomotic leakage (AL) remains one of the most severe postoperative complications in the surgical treatment of rectal cancer. Ischemic microcirculatory disturbances in the anastomotic zone represent a leading factor in the development of this complication and may be exacerbated after neoadjuvant radiotherapy (NRT). Conventional methods for assessing bowel perfusion are largely subjective; therefore, objective intraoperative techniques, particularly indocyanine green (ICG) fluorescence angiography, are gaining increasing importance. In addition, monitoring early inflammatory markers-procalcitonin (PCT) and C-reactive protein (CRP)-in combination with morphological tissue assessment has significant prognostic value for the timely detection of AL. Aim. To evaluate the relationship between intraoperative intestinal wall perfusion, inflammatory biomarker levels, and morphological signs of ischemia in predicting anastomotic leakage after rectal resection. Materials and Methods. A prospective cohort study was conducted involving 107 patients with stage I-III rectal cancer who underwent anterior or low anterior resection with colorectal anastomosis. Patients were divided into two groups according to the method of perfusion assessment: the ICG(-) group, which underwent standard visual evaluation, and the ICG(+) group, in which indocyanine green fluorescence angiography was applied. Clinical, morphological, and laboratory parameters (CRP, PCT), as well as instrumental data from intraoperative angiography, were analyzed. Statistical analysis was performed using the Mann–Whitney U test, correlation analysis, and ROC analysis, with a significance level set at p<0.05. Results. Intraoperative indocyanine green (ICG) fluorescence angiography enabled objective assessment of intestinal wall perfusion and allowed adjustment of resection margins in 20.8% of patients. The use of ICG angiography was associated with a lower incidence of anastomotic leakage (5.6%) compared with the control group (18.1%). In patients with low relative fluorescence intensity (ΔI<25%), morphological signs of ischemic injury of the mucosa were more frequently detected, including edema, crypt destruction, and fibrin thrombi in the submucosal layer, corresponding to grade 2-3 according to the Ischemic Injury Score. Elevated procalcitonin levels above 0.5 ng/mL and C-reactive protein levels above 100 mg/L on the third postoperative day were significantly associated with the development of anastomotic leakage. The combined use of ICG angiography parameters, CRP, PCT, and morphological assessment of ischemia demonstrated high prognostic accuracy for predicting the risk of complications (AUC=0.92). Conclusions. Intraoperative indocyanine green fluorescence angiography is an effective method for assessing intestinal wall perfusion during rectal resection. The integration of ICG angiography data with procalcitonin and C-reactive protein levels, as well as morphological signs of ischemia, allows a comprehensive evaluation of anastomotic viability and improves the accuracy of predicting anastomotic leakage. This approach contributes to early risk identification in patients and may reduce the incidence of postoperative complications.

  • Open Access

    Effectiveness and safety of tumescent anesthesia in the comprehensive management of patients with chronic venous disease of the lower extremities

    by Oleg Atamanyuk, Vasil Skrypko

    Aim. To improve the efficacy of analgesia and reduce the incidence of complications associated with tumescent anesthesia (ТА) during various stages of surgical interventions in patients with chronic venous disease (CVD) of the lower extremities by identifying the optimal technical parameters for its administration. Materials and Methods. A single-center, open-label, non-randomized, prospective study was conducted from 2019 to 2024 and included 591 consecutive patients with clinical manifestations of CVD (C2–C6 according to the CEAP classification). TA was administered using a modified Klein solution under continuous ultrasound guidance at a flow rate of 50 mL/min. The primary endpoint of the study was to evaluate the technical characteristics of TA and the effectiveness of the proposed technique for analgesia during radiofrequency ablation (RFA). The secondary endpoint was to assess the safety of TA and the incidence of complications. Results. A total of 620 lower extremities underwent RFA; 92.7% involved the great saphenous vein (GSV) and 7.3% the small saphenous vein (SSV). Concomitant miniphlebectomy was performed in 85.5% of cases. The mean volume of tumescent solution per centimeter of treated vein was 12.5 mL/cm for the GSV and 13 mL/cm for the SSV. No statistically significant differences were observed between procedures performed as isolated truncal ablation and those combined with miniphlebectomy; however, bilateral procedures demonstrated a statistically significant difference in solution volume (p < 0.05). The perioperative VAS score was 1.9 ± 1.7 cm for isolated RFA and 2.9 ± 1.8 cm for combined treatment with miniphlebectomy, with no significant differences between the groups. Pain scores decreased to 1.2 ± 1.3 cm within 48 hours and increased to 0.68 ± 1.1 cm on postoperative day 7. TA-related complications included ecchymosis in 15.8% of cases and transient paresthesia in 0.7%. No allergic reactions or thermal skin injuries were observed. Conclusions. The use of tumescent anesthesia with a modified solution and the proposed technique demonstrates a high safety profile and provides effective analgesia, enabling comprehensive treatment of patients with chronic venous disease of the lower extremities while avoiding the need for general or spinal anesthesia.

  • Open Access

    Quantitative parameters of venous reflux in patients with chronic diseases of the lower extremities veins

    by O. Yu. Atamanyuk, V. D. Skrypko, M. D. Ryzyuk

    Objective. To analyze quantitative parameters of pathological venous reflux in patients with chronic diseases of the veins of the lower extremities and to evaluate their diagnostic significance. Materials and methods. A prospective single-center study included 73 patients with chronic diseases of the veins of the lower extremities (clinical classes C2–C6). The average age of patients was (48.6 ± 6.4) years, the average body mass index was (26.1 ± 1.2) kg/m2. Distal manual compression and the Valsalva maneuver were used to provoke venous reflux. In the projection of the saphenofemoral junction of the great saphenous vein, its cross-sectional area, duration, volume, and time-averaged reflux velocity were measured. Results. When performing distal manual compression and the Valsalva maneuver, the cross-sectional area of the great saphenous vein was (0.71 ± 0.35) and (0.76 ± 0.39) cm² 2, respectively, and the duration of the reflex was (2.9 ± 1.78) and (3.8 ± 1.64) s, the volume of reflux was (226.17 ± 218.9) and (269.48 ± 288) ml/min, respectively, and the time-averaged reflux velocity was (4.68 ± 3) and (5.25 ± 3.7) cm/s, respectively. A strong positive correlation was found between the area of the large subcutaneous vein in its transverse section and the volume of reflux during both distal manual compression (r=0.85) and the Valsalva maneuver (r=0.75), as well as between the volume and time-averaged reflux velocity. Higher values of the studied parameters were associated with a higher clinical class of chronic venous disease. Conclusions. The volume and time-averaged velocity of reflux can serve as effective criteria for assessing the severity of chronic venous disease.

  • Open Access

    MicroRNA as prognostic markers of thyroid carcinoma

    by А. Я. Пасько, V. D. Skrypko

    Thyroid cancer is the most common malignant endocrine tumor, with a rising incidence worldwide. Despite a generally favorable prognosis, a subset of patients experiences aggressive disease progression and a tendency for recurrence, highlighting the need to identify prognostic markers. The aim — to identify candidate miRNAs that could serve as prognostic indicators of aggressive TC behavior and treatment outcomes. Materials and methods. The analysis was conducted using the UALCAN public database, which provides expression data of miRNAs in both normal and tumor thyroid tissues. Expression levels were compared between normal and malignant samples, as well as among patient subgroups stratified by clinicopathological characteristics, including age, tumor stage, histological type, and lymph node status. Results. Elevated expression of miR-15a-5p, miR-146b-5p, miR-221-5p, and miR-222-3p, as well as reduced levels of miR-199b-5p and miR-484, were found to be significantly associated with the presence of malignancy and tumor aggressiveness. Notably, a inverse correlation was observed between miR-199b-5p expression and patient survival rates, indicating its potential role as a favorable prognostic marker in thyroid carcinoma. Conclusions. A panel of microRNAs (15a-5p, 146b-5p, 199b-5p, 221-5p, 222-3p, and 484) has been identified, demonstrating diagnostic and prognostic potential and may be used in clinical practice for the differential diagnosis of malignant growth in the thyroid gland.


  • Open Access

    Experience of using certain immunocytochemical markers in preoperative prognostication of aggressiveness in highly differentiated thyroid tumors

    by Y. V. Skrypko, V. D. Skrypko, Ю. В. Скрипко

    Objective — to improve treatment outcomes for patients with highly differentiated papillary thyroid microcarcinoma (PTMC) by developing a differentiated surgical approach based on the preoperative assessment of cytokeratin-17 (CK17) and thyroid peroxidase (TPO) expression levels in fine-needle aspiration (FNA) samples of the thyroid gland. Materials and methods. The study included 31 patients with cytologically confirmed PTMC (≤ 10 mm) without signs of autoimmune thyroiditis or metastases. All patients underwent immunocytochemical analysis of thyroid FNA samples to evaluate CK17 and TPO expression levels. Based on the results, patients were stratified into two groups: those with an aggressive tumor phenotype (CK17 ≥ 10%, TPO <25%) and those with a non-aggressive phenotype. Accordingly, patients underwent either total thyroidectomy with lymph node dissection or hemithyroidectomy. Results. In 7 (22.6%) patients, an aggressive immunocytochemical profile was established, which correlated with the detection of follicular-infiltrative or diffuse sclerotic variant of MVP according to histological analysis. The remaining patients were diagnosed with non-aggressive morphological variants (classical, varicose). No recurrence or progression of the disease was recorded during follow-up. A statistically significant (p<0.05) association between high expression of CK-17, decreased TPO levels and aggressive course of MVP was established. Conclusions. Immunocytochemical assessment of the expression of CC-17 and TPO is informative for stratifying the risk of MVP aggressiveness at the preoperative stage. The use of these markers makes it possible to individualise the scope of surgical intervention in accordance with the biological behaviour of the tumour, which is consistent with current recommendations (ATA 2023, NCCN 2024, WHO 2022).

  • Open Access

    Some Aspects of Modern Diagnosis and Surgical Tactics in Follicular Thyroid Neoplasms

    by Andrii Pasko, Vasyl Skrypko

    The study analyzed the examination and treatment outcomes of patients with surgical thyroid pathology. Objective: to systematize preoperative diagnostic methods and develop a comprehensive approach to organ-preserving surgeries in patients with follicular thyroid neoplasms. Material and Methods. The study analyzed the examination and treatment outcomes of 749 patients treated at the Precarpathian Clinical Oncology Center, Ivano-Frankivsk, Ukraine, between 2019 and 2024. All patients underwent fine-needle aspiration biopsy of clinically significant thyroid gland nodules at the preoperative stage. Results. The causes of the disease were as follows: colloid nodular goiter in 566 (75.6%, 95% CI 72.3-78.6%) patients, adenomatous nodular goiter with follicular neoplasms in 72 (9.6%, 95% CI 7.612.0%) cases, papillary carcinoma in 54 (7.2%, 95% CI 5.5-9.3%) patients, suspicious for papillary carcinoma in 17 (2.3%, 95% CI 1.3-3.6%) cases (based on cytological examination), medullary carcinoma in 12 (1.6%, 95% CI 0.8-2.8%) patients, anaplastic carcinoma in 6 (0.8%, 95% CI 0.3-1.7%) cases, and other tumors in 22 (2.9%, 95% CI 1.8-4.4%) patients. The results were statistically processed using the standard software package “Statistica 6.0 for Windows” (StatSoft, USA). Hemithyroidectomy was performed in 28 (42.4%, 95% CI 0.31-0.54%) cases, thyroidectomy in 16 (24.2%, 95% CI 0.12-0.32%) cases, subtotal lobectomy in 19 (28.7%, 95% CI 0.16-0.37%) cases, and lobectomy in 9 (13.6%, 95% CI 0.05-0.20%) cases. Central compartment lymph node dissection as an adjunct to thyroidectomy was performed on six (31.0%, 95% CI 0.32-0.61%) patients. Conclusions. The primary method for preoperative diagnosis of follicular neoplasms is fine-needle aspiration biopsy, followed by cytological examination. In follicular neoplasms against the background of multinodular goiter, thyroidectomy is recommended. In all other cases, the initial surgical approach should prioritize organ-preserving procedures to improve quality of life. The extent of the final surgical intervention depends on the pathological findings. If a patient with follicular neoplasms refuses surgery, prolonged monitoring by an oncological surgeon is essential. Molecular genetic diagnostics can facilitate the preoperative identification of follicular carcinoma, guiding the subsequent treatment algorithm.

  • Open Access

    Morphological Changes in the Colon Wall and Alterations in Endogenous Intoxication Markers in Patients with Obstructive Left-Sided Colon Cancer

    by Vasyl Skrypko, Dmytro Bachynskyi

    The study examined morphological changes in the proximal and distal colon segments in patients with obstructive left-sided colon cancer (OLCC) and conducted a comprehensive assessment of endogenous intoxication markers and morphological alterations in the colon wall at various stages of OLCC progression. The progression of OLCC significantly increased serum endogenous intoxication levels, accompanied by disturbances in the antioxidant system and marked morphological alterations in the colon wall. These changes serve as predictors of purulent inflammatory processes and primary anastomosis leak. Dynamic quantitative assessment of serum procalcitonin (PCT) and C-reactive protein (CRP) levels in the early postoperative period proves to be an effective tool for predicting early postoperative complications, underscoring the clinical significance of these biomarkers. Objective: to assess the relationship between endogenous intoxication markers, acute phase proteins, and morphological changes in the colon wall in patients with OLCC. Material and Methods. The study examined serum levels of endogenous intoxication markers in 115 patients with OLCC during disease progression and 20 apparently healthy individuals. The levels of middle molecules and lipid peroxidation markers (malondialdehyde (MDA) and diene conjugates (DC)) were analyzed in the patient serum and the colon wall. Additionally, the activity of antioxidant system enzymes, including catalase (CAT), superoxide dismutase (SOD), and ceruloplasmin (CP), was studied. The levels of acute phase proteins, specifically CRP and PCT, were also evaluated. Tissue samples up to 0.5 cm in size were obtained from the edges of the proximal and distal colon segments after colectomy for histological examination. These samples were fixed in a 10% formalin solution and processed through alcohol solutions. Paraffin sections, 5-10 µm thick, were prepared and stained with hematoxylin and eosin to evaluate the morphological changes under light microscopy at magnifications of ×100, ×200, and ×400. Results. As OLCC progressed, serum markers of endogenous intoxication increased while antioxidant system effectiveness declined. At various stages of disease progression, the leukocytic index of intoxication, intoxication index, and middle molecule levels were 4.37 (3.45; 5.67) a.u., 8.71 (7.89; 9.21) a.u., and 0.56 (0.43; 1.26) a.u., respectively (p<0.05). In healthy individuals, these values were 0.70 (0.45; 1.1) a.u., 0.95 (0.67; 1.54) a.u., and 0.27 (0.12; 0.67) a.u., respectively. Middle molecule levels progressively increased during OLCC progression: 0.42 (0.38; 0.43) a.u. at the compensation stage, 0.56 (0.51; 0.58) a.u. at the sub-compensation stage, and 0.72 (0.69; 0.73) a.u. at the decompensation stage (p1<0.01, p2<0.01, p3<0.01) compared to a normal level of 0.23 (0.18; 0.25) a.u. Furthermore, as the disease progressed, a gradual rise in lipid peroxidation products, specifically MDA, was observed in both serum and the colon wall. At the compensation, sub-compensation, and decompensation stages, serum MDA levels were 6.39 (6.25; 6.42) nmol/mL, 7.88 (7.62; 7.92) nmol/mL, and 8.11 (8.05; 8.15) nmol/mL, respectively (p1<0.001, p2<0.01, p3<0.05), compared to a normal level of 3.14 (2.58; 3.17) nmol/mL. Similarly, MDA levels in the colon wall increased progressively across the stages, reaching 6.82 (6.49; 6.62) nmol/mL, 7.92 (7.81; 7.89) nmol/mL, and 8.29 (8.11; 8.15) nmol/mL (p1<0.001, p2<0.01, p3<0.05). Serum DC levels increased from 3.11 (3.02; 3.18) a.u. to 4.69 (4.53; 4.82) a.u. during OLCC progression (p1<0.01, p2<0.01, p3<0.01) compared to a normal level of 1.41 (1.32; 1.46) a.u. Similarly, DC levels in the colon wall rose to 4.72 (4.63; 4.80) a.u. compared to a normal level of 1.41 (1.32; 1.46) a.u. (p1<0.01, p2<0.01, p3<0.01). Morphological changes in the colon wall tissues caused by the progressive obstruction process were also studied by assessing the intensity of protein peroxidation processes (POM 356, POM 370, POM 430, POM 530). As the disease progressed, the levels of these peroxidation products significantly increased compared to the control group (p1<0.001, p2<0.01, p3<0.01). At the same time, the antioxidant system exhibited a decrease in CAT and SOD levels. At different stages of OLCC, CAT serum levels were as follows: 8.08 (7.65; 9.12) H2O2/mL at the compensation stage, 6.32 (5.75; 7.31) H2O2/mL at the sub-compensation stage, and 5.27 (4.59; 5.75) H2O2/mL at the decompensation stage compared to a normal value of 12.36 (12.11; 12.65) H2O2/mL (p1<0.001, p2<0.01, p3<0.01). Serum SOD levels also decreased with disease progression: 42.43 (31.75; 51.84) a.u. at the compensation stage, 35.65 (24.72; 45.53) a.u. at the sub-compensation stage, and 32.18 (18.72; 41.15) a.u. at the decompensation stage (p1<0.001, p2<0.01, p3<0.01). The changes in serum CP levels also exhibited a reverse trend. At the compensation stage, the level was higher than the normal value (39.21 a.u.), indicating the body compensatory response to the increased lipid peroxidation products. However, with further progression of OLCC, the CP level decreased to 16.12 (15.26; 16.87) a.u. at the decompensation stage (p1<0.001, p2<0.01, p3<0.01). The changes in serum CRP levels indicated inflammatory response development: on days 2-3 of the postoperative period, the CRP level increased to 15.2 (14.8; 16.8) mg/L, and by day 6, it reached 30.1 (27.8; 34.7) mg/L. Serum PCT concentration also increased: on day 2, it was 1.27 (0.87; 1.45) ng/mL; on day 3 - 2.87 (2.34; 3.24) ng/mL; and on day 6 - 3.21 (2.87; 3.65) ng/mL. These changes are indicative of systemic inflammatory response syndrome, necessitating the administration of antibiotic therapy and, if necessary, further surgical interventions. After resection, morphological examination of tissue samples from the proximal and distal...

  • Open Access

    PATHOMORPHOLOGICAL FEATURES OF THE PANCREAS DEPENDING ON CHRONIC PANCREATITIS DURATION

    by Iurii Mikheiev, Vasyl Skrypko, Andrii Pasko, Oksana Popadynets

    Introduction. Chronic pancreatitis (СР) presents clinically as an inflammatory process that leads to complex morphological changes, resulting in the replacement of pancreatic parenchyma with connective tissue and the development of various complications. Defining an optimal surgical strategy remains a relevant issue today. The purpose of the study was to assess the morphological and immunohistochemical characteristics of the pancreatic parenchyma depending on СР duration. Methods. A total of 147 (57.1%) patients were examined retrospectively. A prospective comparative study involving 257 patients analyzed the short and long-term outcomes to evaluate the effectiveness of the “early surgery” strategy developed at the clinic and the surgical management methods for СР. The study conducted a morphological and immunohistochemical assessment of the pancreatic parenchyma, analyzing the long-term outcomes of the primary pathogenetic surgical treatments for СР. Results. Morpho-functional changes in the pancreatic parenchyma, observed more than three years (median 5.85 years) after the onset of CP clinical manifestations, were characterized by progressive fibrosis due to increased expression of type I collagen and fibronectin, which resulted in dense cuff-like perineural and perivascular fibrosis and stenosis of the pancreatic ducts around tubular complexes, clinically corresponding to the presence of intense pain syndrome. Conclusions. An essential role of pancreatic stellate cells in developing pancreatic parenchymal fibrosis in CP has been established. Fibrotic lesions of the pancreas are irreversible, and the resulting morphological and structural changes lead to both exocrine and endocrine dysfunction. More than three years after the onset of clinical manifestations of CP, type I collagen expression was observed in the acinar tissue, with thin strands detected within the islets of Langerhans. Intraepithelial ductal neoplasia was also identified, which may later progress to ductal adenocarcinoma of the pancreas. It has been demonstrated that the improvement in surgical outcomes for complicated forms of CP with biliary and ductal hypertension is achieved through planned surgery within the first three years of CP development, before the onset of irreversible pathological changes, including the potential for oncological transformation of the pancreas.